D. Henry

发表

Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.

Adam Baldwin, Peter Vandamme, Dirk Gevers, 2009, International journal of systematic and evolutionary microbiology.

Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.

S. Aaron, N. MacDonald, D. Speert, 2000, American journal of respiratory and critical care medicine.

Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.

P. Vandamme, E. Mahenthiralingam, D. Speert, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.

P. Vandamme, T. Coenye, B. Hoste, 2001, International journal of systematic and evolutionary microbiology.

vietnamiensis to Aminoglycosides Susceptibility of Burkholderia In Vitro

R. Hancock, R. Ernst, D. Speert, 2014 .

In Vitro Susceptibility of Burkholderia vietnamiensis to Aminoglycosides

R. Hancock, R. Ernst, D. Speert, 2011, Antimicrobial Agents and Chemotherapy.

Sustained Endemicity of Burkholderia cepacia Complex in a Pediatric Institution, Associated With Contaminated Ultrasound Gel

A. Matlow, D. Speert, D. Henry, 2006, Infection Control & Hospital Epidemiology.

Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

E. Mahenthiralingam, D. Speert, M. Campbell, 2002, American journal of respiratory and critical care medicine.

Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium

J. Lipuma, D. Speert, M. Campbell, 1997, Journal of clinical microbiology.

Burkholderia phenoliruptrix sp. nov., to accommodate the 2,4,5-trichlorophenoxyacetic acid and halophenol-degrading strain AC1100.

P. Vandamme, T. Coenye, D. Speert, 2004, Systematic and applied microbiology.

ISOLATION AND GENETIC FINGERPRINTING OF PSEUDOMONAS AERUGINOSA FROM IRANIAN PATIENTS WITH CYSTIC FIBROSIS USING RAPD-PCR

F. Eftekhar, D. Speert, D. Henry, 2003 .

Identification of Burkholderia cepacia Isolates from Patients with Cystic Fibrosis and Use of a Simple New Selective Medium

J. Lipuma, D. Speert, M. Campbell, 1999, Journal of Clinical Microbiology.

Comparison of Isolation Media for Recovery of Burkholderia cepacia Complex from Respiratory Secretions of Patients with Cystic Fibrosis

P. Vandamme, J. Burns, D. Speert, 1999, Journal of Clinical Microbiology.

Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience.

R. Brant, E. Mahenthiralingam, M. Chilvers, 2015, Annals of the American Thoracic Society.

Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.

P. Vandamme, T. Coenye, J. Lipuma, 2001, International journal of systematic and evolutionary microbiology.

Comparative Genomics of Burkholderia singularis sp. nov., a Low G+C Content, Free-Living Bacterium That Defies Taxonomic Dissection of the Genus Burkholderia

P. Vandamme, B. Currie, A. Carlier, 2017, Front. Microbiol..

Reliability of multilocus sequence typing of the Burkholderia cepacia complex in cystic fibrosis.

C. Dowson, E. Mahenthiralingam, A. Baldwin, 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada

M. Corey, P. Vandamme, E. Mahenthiralingam, 2002, Emerging infectious diseases.

Phenotypic Methods for Determining Genomovar Status of the Burkholderia cepacia Complex

P. Vandamme, T. Coenye, E. Mahenthiralingam, 2001, Journal of Clinical Microbiology.

Differential Mucoid Exopolysaccharide Production by Members of the Burkholderia cepacia Complex

L. M. Moreira, D. Speert, D. Henry, 2008, Journal of Clinical Microbiology.

Identification and Population Structure ofBurkholderia stabilis sp. nov. (formerly Burkholderia cepacia Genomovar IV)

P. de Vos, P. Vos, P. Vandamme, 2000, Journal of Clinical Microbiology.

Disk elution method for MICs and MBCs

J. A. Smith, D. Henry, E. Wilson, 1990, Antimicrobial Agents and Chemotherapy.

Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes

J. Ngui-Yen, J. A. Smith, D. Henry, 1986, Journal of clinical microbiology.

In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents

A. Smith, J. Ngui-Yen, J. A. Smith, 1985, Antimicrobial Agents and Chemotherapy.

Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools.

P. Vandamme, T. Coenye, J. Lipuma, 2002, FEMS immunology and medical microbiology.

Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex.

P. Vandamme, J. Lipuma, C. Dowson, 2008, International journal of systematic and evolutionary microbiology.

Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting

M E Campbell, E. Mahenthiralingam, D. Speert, 1996, Journal of clinical microbiology.

Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: A pilot study in a Sydney clinic

P. Bye, G. Marks, E. Mahenthiralingam, 2002, Respirology.

Elucidating Global Epidemiology of Burkholderia multivorans in Cases of Cystic Fibrosis by Multilocus Sequence Typing

P. Vandamme, P. Dřevínek, J. Lipuma, 2007, Journal of Clinical Microbiology.

Environmental Burkholderia cepacia Complex Isolates from Human Infections

Adam Baldwin, Luigi Chiarini, Peter Vandamme, 2007, Emerging infectious diseases.

Epidemiology of Burkholderia Infections in People with Cystic Fibrosis in Canada between 2000 - 2017.

M. Sadarangani, M. Chilvers, M. Campbell, 2020, Annals of the American Thoracic Society.

Clinical comparison of isolator and BACTEC 660 resin media for blood culture

J. A. Smith, D. Henry, M. Kelly, 1990, Journal of clinical microbiology.